Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
HIV Infections
Interventions
DRUG

apricitabine

800mg BID apricitabine orally for 48 weeks

DRUG

lamivudine

150mg BID lamivudine orally for 48 weeks

Trial Locations (100)

0

Hospital Nacional CASE-EsSalud, Arequipa

1

Hospital Dos de Mayo, Lima

Via Libre, Lima

14

Investigaciones Medicas en Salud, Lima

31

Hospital Nacional Cayetano Heredia, Lima

149

"Istituto Nazionale Malattie Infettive Lazzaro Spallanzani IRCCS", Roma

731

Instituto De Investigacion Cientifica, Ponce

909

Hope Clinical Research, San Juan

1000

Hopitaux IRIS Sud, Brussels

1200

Cliniques Universitaires Saint-Luc, Brussels

2000

Prins Leopold Institute voor Tropische Geneeskunde, Antwerp

2010

407 Doctors, Darlinghurst

2145

Westmead Hospital, Westmead

2150

Parramatta Sexual Health Clinic, Parramatta

3050

Royal Melbourne Hospital, Parkville

3053

Carlton Clinic, Carlton

Melbourne Sexual Health Centre, Carlton

3141

Prahran Market Clinic, South Yarra

10149

Comprensorio Amedeo di Savoia - Birago Di Vische, Torino

10270

Mahidol University Hospital for Tropical Diseases, Bangkok

10330

Pharmongkutklao Hospital, Bangkok

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok

10400

Ramathibodi Hospital, Mahidol University, Bangkok

10700

Sirraj Hospital, Mahidol Universoty, Bangkok

11000

Bamrasnaradura Institution, Nonthaburi

12157

EPIMED GmbH, Berlin

13353

Charite-Universitatsmedizin Berlin, Berlin

16132

Azienda Ospedaliera Universitaria San Martino, Genova

20007

Georgetown University, Washington D.C.

20037

George Washington University, Washington D.C.

20127

Fondazione Centro San Raffaele del Monte Tabor, Milan

20157

Ospedale Luigi Sacco, Milan

30159

Dr. med. Birger Kuhlmann, Hanover

30308

Aids Research Consortium Of Atlanta Inc., Atlanta

30309

Atlanta Infectious Disease Group, PC, Atlanta

31096

Rambam Medical Center, Haifa

32803

Orlando Immunology Center, Orlando

32960

Treasure Coast Infectious Diseases Consultants, Vero Beach

33316

Gary Richmond, MD, Fort Lauderdale

33614

Infectious Disease Research Institute, Inc, Tampa

35128

Azienda Ospedaliera di Padova, Padua

40002

Khon Kaen University, Khon Kaen

41100

Azienda Ospedaliero-Universitaria di Modena Policlinico, Modena

44100

Azienda Ospedaliera Universitaria di Ferrara Arcispedale S.Anna, Ferrara

44137

Klinikum Dortmund gGmbH, Dortmund

44791

Ruhr-Universitat Bochum, Bochum

45122

Universitatsklinikum Essen, Essen

50002

Maharaj Nakorn Chiang Mai, Chiang Mai University, Chiang Mai

50011

Ospedale S.Maria Annunziata, Antella

52621

The Chaim Sheba Medical Center, Ramat Gan

53105

Universitatsklinikum Bonn, Bonn

60590

Klinikum der Johann-Wolfgang Goethe-Universitat, Frankfurt

60611

Northwestern University, Chicago

64239

Tel-Aviv Sourasky Medical Center, Tel Aviv

67214

University of Kansas School of Medicine, Wichita

70197

Gemeinschaftspraxis E. Schnaitmann, Dr. med. A. Schaffert, Dr. med. A. Trein, Dr. med. E. Ibler, Stuttgart

Praxis Dres. Ulmer, Frietsch, Muller, Stuttgart

75204

Nicholaos C Bellos, MD, PA, Dallas

75246

North Texas Infectious Diseases Consultants, P.A., Dallas

75605

DCOL Center for Clinical Research, Longview

76100

Kaplan Medical Center, Rehovot

76104

Tarrant County Infection Disease Associates, Fort Worth

77004

Therapeutic Concepts, Houston

77098

Resarch Access Network, Houston

78705

Central Texas Clinical Research, Austin

79098

Praxis fuer Innere Medizin, Freiburg im Breisgau

80131

Azienda Ospedaliera Cotugno, Napoli

80204

Denver Health & Hospital Authority, Denver

80336

Klinikum der Universitat Munchen - Innenstadt, München

84101

Soroka University Medical Center, Beersheba

85006

Southwest Center for HIV/AIDS, Phoenix

90069

AIDS Research Alliance, West Hollywood

90762

Praxis Dr.Schneider, Fürth

90813

Living Hope Clinical Foundation, Inc, Long Beach

91120

Hadassah University Hospital Ein Kerem, Jerusalem

94115

Kaiser Permanente Medical Center, San Francisco

97209

The Research & Education Institute, Portland

98104

Swedish Medical Center, Seattle

35294-2170

UAB, 845 19th St South, South Beville Biomedical Research Building, Birmingham

University of Alabama at Birmingham, Birmingham

96816-2333

University of Hawaii, Honolulu

02115

Fenway Community Health Center, Boston

02215-3319

Community Research Intiative of New England, Boston

08844-4254

I.D. Care, Inc., Hillsborough

07102

Saint Michael's Medical Center, Newark

44304-1430

Summa Health System, Akron

77555-0435

University of Texas Medical Brach, Galveston

Unknown

The Alfred, Melbourne

Edgardo Rebagliati Hospital, Lima

V6Z 2C7

Ubc Downtown I.D. Clinic, Vancouver

L8N 3Z5

Hamilton Health Sciences Corporation, Hamilton

H5G 2C4

University Health Network, Toronto

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

G1V 4G2

Centre Hospitalier Universitaire de Quebec, Québec

00936-5067

University of Puerto Rico, San Juan

B9 5SS

Birmingham Heartlands Hospital, Birmingham

EC1A 7BE

St Bartholomew's Hospital, London

NW3 2QG

Royal Free Hospital, London

SE5 9RJ

Guy's King's & St. Thomas' School of Medicine, London

W2 1NY

St Mary's Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Avexa

INDUSTRY

NCT00612898 - Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection | Biotech Hunter | Biotech Hunter